Home / Health / Mass. Medicaid Cuts Weight Loss Drugs, Patients Fear Setback
Mass. Medicaid Cuts Weight Loss Drugs, Patients Fear Setback
3 Jul
Summary
- 22,000 people may lose access to life-changing weight loss medications.
- MassHealth cites overwhelming expense of GLP-1s for weight loss.
- Medicare begins pilot program covering some GLP-1s for seniors.
MassHealth is ending coverage for GLP-1 medications when prescribed solely for weight loss, impacting an estimated 22,000 individuals who depend on Medicaid. This decision, effective Friday, comes after these drugs facilitated significant health transformations, such as Carolina Martinez losing 80 pounds and reversing hypertension. Patients are expressing deep concern about regaining weight and related health problems.
Doctors emphasize the effectiveness of GLP-1s in managing obesity, a condition linked to severe health issues. The high cost of these drugs, hundreds of dollars monthly, makes them inaccessible for many Medicaid recipients. While Medicare is launching a pilot program to cover some GLP-1s for beneficiaries, Massachusetts is cutting access due to state budget pressures and federal Medicaid reforms.
MassHealth will continue to cover GLP-1s for diabetes and other specified conditions, but not for weight loss alone. This move is projected to save the state approximately $15 million. The change risks making highly effective treatments available only to the affluent, impacting both adults and an estimated 2,500 children who could face renewed health challenges and social stigma.
